Christopher Rudolf

Press Release: Volv Global Expands Office Footprint to Power Next-Generation AI Innovation in Healthcare

ÉPALINGES, Switzerland, March 5, 2025 /PRNewswire-PRWeb/   Volv Global expands office footprint to more than double its office space for…

1 year ago

Where technology meets Human: Volv Global at the World Orphan Drug Congress USA 2025

Volv Global sits at the crucial intersection between technology and human beings, i.e., patients and physicians, supporting favourable patient journeys…

1 year ago

News Article: Volv Global Tracks Nearly Undetectable Diseases

This article is also available in French and originally published 24 Heures. Read the original article Based in Épalinges, the small…

1 year ago

Finding Patients for Rare Diseases: A Case Study

By Christopher Rudolf, Volv Global An AI Methodology for Finding Patients with Rare Diseases: Volv Global’s inTrigue Finding patients with…

2 years ago

White Paper: The Path to Rare Disease Clinical Trial Innovation

By Volv Global SA and WODC EU contributors   Executive Summary For decades, the pharmaceutical industry has faced the same…

3 years ago

Tamsyn’s Experience: Poland Syndrome and the problems beyond diagnosis

By Christopher Rudolf, Volv Global Rare disease patients and the journey to diagnosis, treatment, and support For patients with rare…

5 years ago

Paul’s Experience: Narcolepsy and diagnosis – an 8 year odyssey

By Christopher Rudolf, Volv Global Introduction Rare Disease Day highlights the voices, stories, and experiences of millions of people living…

5 years ago